- Fee assured
- Verified this account
Dr Rakesh Popat is a Consultant Haematologist with specialist expertise in Multiple Myeloma. He has particular experience with novel treatments including immunotherapies such as CAR-T cell therapy and new antibody approaches. His NHS base is at University College Hospital, London where he leads the Myeloma Clinical Trials Program and is the Cancer Program lead for the NIHR UCLH Clinical Research Facility.
Dr Popat is on the leadership boards of the UK Myeloma Forum, The UK Myeloma Research Alliance and the European Myeloma Network. In addition he is the Haematology lead for the North Thames Clinical Research Network. He completed a PhD in novel treatments for Myeloma and was awarded a Fellowship to attend the Dana Farber Cancer Institute, Boston USA as part of this.
Areas of interest
Multiple myeloma all aspects, with a specific interest in new treatments
Current NHS consultant posts held
University College London Hospitals NHS Foundation Trust, London, UK
New treatments for multiple myeloma. I lead the clinical trials program for myeloma and am the Cancer Portfolio lead for the NIHR UCLH Clinical Research Facility.
Fellowship to attend the Dana Farber Cancer Institute, Boston, USA
(Additional) Languages spoken
- Gujarati - Conversational
- BSc (Hons) Immunology University of London 1994
- MBBS University of London 1997
- MRCP Royal College of Physicians, UK 2001
- PhD University of London 2010
- FRCPath Royal College of Pathologists 2010
Reference number 4432920
Professional bodies (positions held - last 3 yrs)
- Honorary Clinical Senior Lecturer UCL Cancer Institute 2014